Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 56

Results For "2020"

617 News Found

Panacea Biotec to manufacture 10 crore doses per year of Sputnik V
News | May 24, 2021

Panacea Biotec to manufacture 10 crore doses per year of Sputnik V

First batch produced at Panacea Biotec’s facilities at Baddi will be shipped to the Gamaleya Center for quality control and full scale production of the vaccine is due to start this summer


Orchid Pharma Q4FY21 consolidated loss at Rs. 24.72 Cr
News | May 23, 2021

Orchid Pharma Q4FY21 consolidated loss at Rs. 24.72 Cr

The company reported total income of Rs.455.28 crores during the 12 months period ended March 31, 2021


Sun Pharma Advanced Research Q4FY21 loss at Rs. 56.72 Cr
News | May 18, 2021

Sun Pharma Advanced Research Q4FY21 loss at Rs. 56.72 Cr

The company has posted net loss of Rs. 99.54 crores for the period ended March 31, 2020


Aarti Drugs Q4FY21 consolidated net profit drops to Rs. 51.65 Cr
News | May 16, 2021

Aarti Drugs Q4FY21 consolidated net profit drops to Rs. 51.65 Cr

Aarti Drugs has reported total income of Rs.2159.30 crores during the 12 months period ended March 31, 2021


Alembic gets USFDA approval for Lurasidone Hydrochloride tablets
News | May 15, 2021

Alembic gets USFDA approval for Lurasidone Hydrochloride tablets

Lurasidone Hydrochloride tablets are also indicated for adjunctive treatment with lithium or valproate in adult patients with major depressive episode associated with bipolar I disorder


Dr. Reddy's Laboratories see marginal dip in FY 2021 PAT
News | May 15, 2021

Dr. Reddy's Laboratories see marginal dip in FY 2021 PAT

Dr. Reddy's Laboratories has reported total income of Rs.19338.9 crores during FY ended March 31, 2021


Cipla reports Q4FY21 consolidated net profit of Rs. 413.38 Cr
News | May 15, 2021

Cipla reports Q4FY21 consolidated net profit of Rs. 413.38 Cr

The company has reported total income of Rs.19425.58 crores during FY ended March 31, 2021


Eris Lifesciences reports Q4FY21 consolidated net profit of Rs. 68.24 Cr
News | May 13, 2021

Eris Lifesciences reports Q4FY21 consolidated net profit of Rs. 68.24 Cr

Eris Lifesciences has reported total income of Rs.1220.57 crores during the 12 months period ended March 31, 2021


Lupin reports Q4FY21 consolidated PAT of Rs. 460.36 Cr
News | May 13, 2021

Lupin reports Q4FY21 consolidated PAT of Rs. 460.36 Cr

It reported total income of Rs.15299.25 crores during the FY ended March 31, 2021


Brinton triples production of COVID-19 drug Favipiravir
News | May 12, 2021

Brinton triples production of COVID-19 drug Favipiravir

Favipiravir is close to Remdesivir, Remdesivir is used to treat moderate to severe cases while Favipiravir is used to treat mild to moderate cases